Key result
Prediabetes diagnostic tests identify heterogeneous populations with varying risk of progression to type 2 diabetes.
Answers are grounded in this paper and cite their sources.
We thank Sonne and Hemmingsen (1) for their thoughtful critique of the American Diabetes Association’s Standards of Medical Care in Diabetes—2017 (Standards of Care) (2). As they point out, the Standards of Care now highlight a prediabetes screening tool that was developed in 1995 (3), revised in 2012 (4), and most recently validated in 2016 (5). The Standards of Care also recommend regular monitoring for those with prediabetes, intensive lifestyle intervention for diabetes prevention, and consideration of metformin therapy for selected individuals with prediabetes (6). We acknowledge that the use of three different diagnostic tests to define prediabetes identifies heterogeneous groups. Although values above the diagnostic threshold for each of the tests have been associated with increased risk of progression to type 2 diabetes (T2D) (7,8), the thresholds for the individual …
No takes yet. Share an insight, caveat, or question.
Herman et al. (2017) conducted a letter in Prediabetes and Type 2 Diabetes. Three different diagnostic tests used to define prediabetes identify heterogeneous groups with increased risk of progression to type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: